ANDROGEL 50mg Price

Overview

Welcome to Dwaey, specifically on ANDROGEL 50mg Gel page.
This medicine contains an important and useful components, as it consists of Testosterone.
ANDROGEL 50mg is available in the market in concentration 50mg/Sachet and in the form of Gel.

SOLVAY PHARMACEUTICALS GmbH is the producer of ANDROGEL 50mg and it is imported from GERMANY, The most popular alternatives of ANDROGEL 50mg are listed downward .

Mode Of Action

Testosterone is the principal endogenous androgen responsible for promoting the growth and development of male sexual organs and maintaining secondary sex characteristics in androgen-deficient males.

Indication

• Hypogonadism
• Testosterone replacement therapy

Precaution

Cardiovascular disorders, skeletal metastases, renal or hepatic impairment, epilepsy, migraine, diabetes or other conditions which may be aggravated by fluid retention, eg heart failure. Elderly, prepubertal boys. Monitor signs of virilization (females) and development of priapism or excessive sexual stimulation (males). Periodic haemoglobin, lipid determinations and rectal prostate examination. Lactation: Drug is excreted into breast milk; use is contraindicated

Side Effects

• >10% Pruritus at application site (37%)
• Skin reactions at application site (16.1%)
• Blisters under skin (12%) 1-10% Erythema at application site (7%)
• Vesicles at application site (6%)
• Allergic contact dermatitis (4%)
• Burning at application site (3%)
• Induration at application site (3%) Frequency Not Defined Abnormal dreams
• Acne
• Anaphylaxis
• Bladder irritability
• Breast soreness
• Cholestatic jaundice
• Deep vein thrombosis
• Dry skin
• Fatigue
• Gynecomastia
• Headache
• Insomnia
• Menstrual irregularities
• Priapism
• Suppression of factors II
• V
• VII
• Virilization

Contra indication

Hypercalcaemia or hypercalciuria, males with breast or prostate carcinoma. Pregnancy and lactation.

Pregnancy and lactation

Pregnancy category: X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.